| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8453767 | Lung Cancer | 2018 | 9 Pages |
Abstract
These results suggest that lung cancer screening may be cost-effective in Switzerland, a high-income, European country with high smoking prevalence.
Keywords
QALYLDCTPLCONLSTUSPSTFICERLYGDRGNCICost-effectivenessLow-dose computed tomographyLung cancerQuality-adjusted life-yearScreeningNational lung screening trialModellingNational Cancer InstituteIncremental cost-effectiveness ratioNELSONUnited States Preventive Services Task ForcePreventiondiagnosis related group
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Yuki Tomonaga, Kevin ten Haaf, Thomas Frauenfelder, Malcolm Kohler, Roger D. Kouyos, Mohaned Shilaih, Matthias Lorez, Harry J. de Koning, Matthias Schwenkglenks, Milo A. Puhan,